185 related articles for article (PubMed ID: 22142826)
1. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
[TBL] [Abstract][Full Text] [Related]
3. Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity.
Ricaud S; Vernus B; Bonnieu A
Exp Cell Res; 2005 Dec; 311(2):192-204. PubMed ID: 16236281
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
Zhuang Y; Faria TN; Chambon P; Gudas LJ
Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
7. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
Wan H; Dawson MI; Hong WK; Lotan R
Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
[TBL] [Abstract][Full Text] [Related]
9. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
Zhao Z; Zhang ZP; Soprano DR; Soprano KJ
Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808
[TBL] [Abstract][Full Text] [Related]
10. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
11. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
12. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion.
Vo HP; Crowe DL
Anticancer Res; 1998; 18(1A):217-24. PubMed ID: 9568080
[TBL] [Abstract][Full Text] [Related]
17. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.
Rigas JR; Dragnev KH
Oncologist; 2005 Jan; 10(1):22-33. PubMed ID: 15632250
[TBL] [Abstract][Full Text] [Related]
19. Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells.
Kanki K; Akechi Y; Ueda C; Tsuchiya H; Shimizu H; Ishijima N; Toriguchi K; Hatano E; Endo K; Hirooka Y; Shiota G
J Hepatol; 2013 Nov; 59(5):1037-44. PubMed ID: 23831118
[TBL] [Abstract][Full Text] [Related]
20. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]